NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
GRANULES INDIA LTD. (BSE: 532482)
532482 Technical Analysis
5
As on 24th Dec 2024 532482 SHARE Price closed @ 596.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 396.82 & Strong Buy for SHORT-TERM with Stoploss of 446.40 we also expect STOCK to react on Following IMPORTANT LEVELS. |
532482SHARE Price
Open | 586.00 | Change | Price | % |
High | 607.50 | 1 Day | 9.60 | 1.64 |
Low | 585.50 | 1 Week | 71.10 | 13.53 |
Close | 596.65 | 1 Month | 71.10 | 13.53 |
Volume | 112608 | 1 Year | 210.45 | 54.49 |
52 Week High 607.50 | 52 Week Low 382.05 |
BSE INDIA Most Active Stocks
532822 | 7.47 | -0.13% |
532411 | 0.41 | 0.00% |
517001 | 0.09 | 12.50% |
511700 | 1.01 | -0.98% |
512149 | 0.88 | 0.00% |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
532775 | 2.04 | -0.97% |
531328 | 1.05 | 0.96% |
532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
532482 Daily Charts |
532482 Intraday Charts |
Whats New @ Bazaartrend |
532482 Free Analysis |
|
532482 Important Levels Intraday
RESISTANCE | 639.04 |
RESISTANCE | 625.45 |
RESISTANCE | 617.04 |
RESISTANCE | 608.64 |
SUPPORT | 584.66 |
SUPPORT | 576.26 |
SUPPORT | 567.85 |
SUPPORT | 554.26 |
532482 Target May 2025
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
532482 Weekly Target
4th UP Target | 0.00 |
3rd UP Target | 0.00 |
2nd UP Target | 0.00 |
1st UP Target | 0.00 |
1st DOWN Target | 0.00 |
2nd DOWN Target | 0.00 |
3rd DOWN Target | 0.00 |
4th DOWN Target | 0.00 |
532482 Target2025
4th UP Target | 679.03 |
3rd UP Target | 591.28 |
2nd UP Target | 537.03 |
1st UP Target | 482.79 |
1st DOWN Target | 328.01 |
2nd DOWN Target | 273.77 |
3rd DOWN Target | 219.52 |
4th DOWN Target | 131.77 |
GRANULES INDIA LTD. ( BSE INDIA Symbol : 532482 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
532482 Other Details
Segment | EQ | |
Market Capital | 96988594176.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers - Major | |
Offical website | > echo $website ; ?> |
532482 Address
![]() |
532482 Latest News
532482 Business Profile
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India. Address: My Home Hub, Hyderabad, India, 500081
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service